Objetivo: Caracterizar o perfil clínico-laboratorial de pacientes hospitalizados acometidos por lesão por pressão (LP). Método: Estudo retrospectivo e descritivo, que incluiu dados de prontuários eletrônicos de 95 pacientes acometidos por LP durante a hospitalização. Resultados: Houve predomínio do sexo feminino (52,6%), média de idade 74,8 ± 14 anos, tempo médio de internação foi de 76,9 ± 88,8 dias. A maioria esteve internada na unidade de terapia intensiva, com uma média de 17,86 ± 36,58 dias. Com relação à condição clínica, 60% estavam em uso de ventilador mecânico quando desenvolveram a LP, 37,9% tinham a necessidade de hemodiálise, 30,4% foram diagnosticados com algum grau de desnutrição energético-proteica e 54,7% evoluíram para o óbito. As comorbidades mais frequentes foram hipertensão (63,16%), diabetes (43,16%) e neuropatia (33,68%). Quanto ao perfil laboratorial, hipoalbuminemia (97,3%), hiperglicemia (87,8%), anemia (84,4%) e hiperuremia (78,9%) estiveram presentes em mais de dois terços da amostra. Conclusão: Este estudo permitiu conhecer o perfil de pacientes acometidos por LP durante internação hospitalar, o que pode servir de base para desenvolver ações preventivas eficazes embasadas cientificamente.
Purpose to evaluate the efficacy of orofacial myofunctional therapy in improving orofacial function and nasal breathing in patients with asthma and rhinitis and, consequently, achieve clinical control of these conditions. Research strategies We used the elements of the PICOT method (study population, intervention, comparison, outcomes and type of studies) to define the eligibility criteria: (1) Population: patients with asthma and rhinitis; (2) Intervention: orofacial myofunctional therapy to improve chewing, swallowing, and breathing; (3) Comparison: control group without orofacial myofunctional therapy; (4) Predefined outcomes: clinical control of asthma and improvement of orofacial functions and nasal breathing; (5) Study type: clinical trials. The data were collected from PubMed, SCOPUS, Web of Science, Science Direct, LILACS, Google Scholar, Cochrane Central Register of Controlled Trials (CENTRAL), OATD, and Open Thesis, in November 2018. Selection criteria Randomized controlled trials published in full-text versions without language restriction, no filter was used. Data analysis Demographic characteristics of study participants, specific diagnosis of asthma and control medication, type, duration, intensity and follow-up of orofacial myofunctional therapy, and outcome data. The risk of bias was assessed according to the Cochrane guidelines for clinical trials. Results One study met the eligibility criteria: although the study has shown an improvement of functional control and clinical scores of asthma, the evidence is very low. Conclusion There is no scientific evidence on the efficacy of orofacial myofunctional therapy in improving clinical control, orofacial function, and nasal breathing in patients with asthma and rhinitis.
Objective: To characterize the clinical and laboratory profile of hospitalized patients affected by pressure injury (PI). Method: Retrospective and descriptive study, which included data from electronic medical records of 95 patients affected by PI during hospitalization. Results: There was a predominance of females (52.6%), mean age 74.8 ± 14 years, mean hospital stay was 76.9 ± 88.8 days. Most were admitted to the intensive care unit, with an average of 17.86 ± 36.58 days. Regarding the clinical condition, 60% were using a mechanical ventilator when they developed PI, 37.9% needed hemodialysis, 30.4% were diagnosed with some degree of protein-energy malnutrition and 54.7% progressed to death. The most frequent comorbidities were hypertension (63.16%), diabetes (43.16%) and neuropathy (33.68%). As for the laboratory profile, hypoalbuminemia (97.3%), hyperglycemia (87.8%), anemia (84.4%) and hyperuremia (78.9%) were present in more than two thirds of the sample. Conclusion: This study allowed to know the profile of patients affected by PI during hospitalization, which can serve as a basis for developing scientifically based effective preventive actions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.